Clinical trial
Study of Nesiritide in Diastolic Heart Failure.
NCT00309868 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00309868 |
|---|---|
| Title | Study of Nesiritide in Diastolic Heart Failure. |
| Official title | A Study of the Acute Hemodynamic and Myocardial Effects of Nesiritide in Diastolic Heart Failure. |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Scios, Inc. Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diastolic Heart Failure |
| Intervention type | Drug |
| Interventions | neseritide |
| Enrollment | 20 |
| Start date | Dec 1, 2002 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Apr 3, 2006 |
| Last update posted | Mar 26, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: